$2.45T
Total marketcap
$67.11B
Total volume
BTC 50.68%     ETH 15.66%
Dominance

Clarivate CLVT Stock

7.07 USD {{ price }} -3.809520% {{change_pct}}%
Exchange
NYSE
Market Cap
4.72B USD
LOW - HIGH [24H]
7.07 - 7.27 USD
VOLUME [24H]
2.44M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.47 USD

Clarivate Price Chart

Clarivate CLVT Financial and Trading Overview

Clarivate stock price 7.07 USD
Previous Close 8.9 USD
Open 8.83 USD
Bid 8.04 USD x 3000
Ask 9.48 USD x 1400
Day's Range 8.83 - 9.2 USD
52 Week Range 7.16 - 14.99 USD
Volume 4.54M USD
Avg. Volume 5.53M USD
Market Cap 6.21B USD
Beta (5Y Monthly) 1.099148
PE Ratio (TTM) N/A
EPS (TTM) -1.47 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 11.95 USD

CLVT Valuation Measures

Enterprise Value 12.22B USD
Trailing P/E N/A
Forward P/E 9.88172
PEG Ratio (5 yr expected) 1.2
Price/Sales (ttm) 2.3642862
Price/Book (mrq) 1.1152912
Enterprise Value/Revenue 4.653
Enterprise Value/EBITDA 12.573

Trading Information

Clarivate Stock Price History

Beta (5Y Monthly) 1.099148
52-Week Change -30.64%
S&P500 52-Week Change 20.43%
52 Week High 14.99 USD
52 Week Low 7.16 USD
50-Day Moving Average 8.33 USD
200-Day Moving Average 9.58 USD

CLVT Share Statistics

Avg. Volume (3 month) 5.53M USD
Avg. Daily Volume (10-Days) 4.89M USD
Shares Outstanding 675.76M
Float 513.32M
Short Ratio 0
% Held by Insiders 9.59%
% Held by Institutions 92.42%
Shares Short 7.06K
Short % of Float 0%
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -151.75%
Operating Margin (ttm) 10.10%
Gross Margin 64.42%
EBITDA Margin 37.00%

Management Effectiveness

Return on Assets (ttm) 0.98%
Return on Equity (ttm) -42.70%

Income Statement

Revenue (ttm) 2.63B USD
Revenue Per Share (ttm) 3.9 USD
Quarterly Revenue Growth (yoy) -5.00000000000000000000000000000000%
Gross Profit (ttm) 1.71B USD
EBITDA 972M USD
Net Income Avi to Common (ttm) -4061700096 USD
Diluted EPS (ttm) -6.29
Quarterly Earnings Growth (yoy) -37.39%

Balance Sheet

Total Cash (mrq) 364.2M USD
Total Cash Per Share (mrq) 0.54 USD
Total Debt (mrq) 4.98B USD
Total Debt/Equity (mrq) 71.6 USD
Current Ratio (mrq) 0.902
Book Value Per Share (mrq) 8.24

Cash Flow Statement

Operating Cash Flow (ttm) 669.4M USD
Levered Free Cash Flow (ttm) 378.86M USD

Profile of Clarivate

Country United States
State N/A
City London
Address 70 St. Mary Axe
ZIP EC3A 8BE
Phone 44 20 7433 4000
Website https://www.clarivate.com
Industry Information Technology Services
Sector(s) Technology
Full Time Employees 11600

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Q&A For Clarivate Stock

What is a current CLVT stock price?

Clarivate CLVT stock price today per share is 7.07 USD.

How to purchase Clarivate stock?

You can buy CLVT shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Clarivate?

The stock symbol or ticker of Clarivate is CLVT.

Which industry does the Clarivate company belong to?

The Clarivate industry is Information Technology Services.

How many shares does Clarivate have in circulation?

The max supply of Clarivate shares is 668.14M.

What is Clarivate Price to Earnings Ratio (PE Ratio)?

Clarivate PE Ratio is now.

What was Clarivate earnings per share over the trailing 12 months (TTM)?

Clarivate EPS is -1.47 USD over the trailing 12 months.

Which sector does the Clarivate company belong to?

The Clarivate sector is Technology.

Clarivate CLVT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NYSE COMPOSITE (DJ) NYA 17639.04 USD
-1.54